The 20.7% three‑month surge—more than 9 percentage points above the benchmark—signals that recent catalysts are resonating strongly with investors and could sustain short‑term buying pressure if momentum persists.
The negative five‑year return (-3.3%) indicates that recent earnings growth may be fragile; if macroeconomic stress re‑elevates credit losses or squeezes net interest margins, the stock could revert to underperformance, potentially eroding its decade‑long advantage.
The combination of >100% institutional ownership and an RSI above 70 implies that a modest pullback (e.g., a 5–7% decline) could trigger forced sales by leveraged funds, potentially accelerating downside pressure.
The 5.8% YoY revenue surge—more than six times the three‑year CAGR—signals a potentially sustainable inflection point that could lift cash flow generation and justify a higher valuation multiple if maintained.
The net margin of 4.9% leaves only $0.05 of profit for every dollar of revenue; a 10% rise in operating expenses would cut net income by roughly $2.5 M, tightening cash flow and potentially forcing dividend cuts or share buybacks.
The 80% plunge in net profit margin (24.9% → 4.9%) is the dominant driver of ROE compression, signaling that operating profitability has fundamentally deteriorated and jeopardizes dividend sustainability.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 2.7 | 4.9 | 0.08 | 6.78 | 3.0 | 0.5 | 0.4 |
| 2024 | 1.8 | 3.3 | 0.08 | 6.68 | 1.8 | 0.3 | |
| 2023 | 4.8 | 8.7 | 0.09 | 6.19 | 3.9 | 0.8 | |
| 2022 | 11.5 | 20.3 | 0.09 | 6.00 | 11.8 | 1.9 | |
| 2021 | 13.2 | 25.6 | 0.07 | 6.94 | 11.1 | 1.9 | |
| 2020 | 8.8 | 17.2 | 0.06 | 8.17 | 7.0 | 1.1 | |
| 2019 | 9.2 | 17.1 | 0.07 | 7.95 | 5.9 | 1.2 | |
| 2018 | 8.1 | 18.2 | 0.06 | 7.16 | 6.0 | 1.1 | |
| 2017 | 9.2 | 18.4 | 0.06 | 8.93 | 7.1 | 1.0 | |
| 2016 | 7.2 | 14.2 | 0.06 | 9.13 | 5.5 | 0.8 | |
| 2015 | 10.9 | 24.9 | 0.07 | 6.31 | 8.7 | 1.7 |
With ROIC at only 3.0% versus an estimated weighted average cost of capital around 7–8%, the firm is eroding shareholder value on a per‑capital basis; continued underperformance could force asset write‑downs or aggressive deleveraging, pressuring liquidity.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 4513 | 0 | 0 | 64 | 0 | 0 |
| 2024 | 4453 | 0 | 0 | 120 | 0 | 0 |
| 2023 | 4136 | 0 | 0 | 88 | 0 | 0 |
| 2022 | 3871 | 0 | 0 | 75 | 0 | 0 |
| 2021 | 4919 | 0 | 0 | 87 | 0 | 0 |
| 2020 | 5813 | 0 | 0 | 101 | 0 | 0 |
| 2019 | 5389 | 0 | 0 | 103 | 0 | 0 |
| 2018 | 5842 | 0 | 0 | 107 | 0 | 0 |
| 2017 | 6482 | 0 | 0 | 116 | 0 | 0 |
| 2016 | 6628 | 0 | 0 | 114 | 0 | 0 |
| 2015 | 5279 | 0 | 0 | 69 | 0 | 0 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $6381M | $5439M | $942M | $-248M | $248M | $613M | ||
| 2024 | $5949M | $5058M | $891M | $142M | $-188M | $330M | $417M | $4821M |
| 2023 | $5347M | $4483M | $864M | $405M | $119M | $287M | $586M | $3977M |
| 2022 | $5334M | $4445M | $889M | $179M | $-229M | $408M | $663M | $4172M |
| 2021 | $5956M | $5097M | $859M | $357M | $-26M | $383M | $566M | $4649M |
| 2020 | $5936M | $5209M | $727M | $428M | $113M | $314M | $539M | $4720M |
| 2019 | $5060M | $4424M | $637M | $559M | $361M | $198M | $447M | $3792M |
| 2018 | $4560M | $3923M | $637M | $422M | $188M | $235M | $571M | $3455M |
| 2017 | $3499M | $3107M | $392M | $464M | $330M | $134M | $385M | $2633M |
| 2016 | $2641M | $2352M | $289M | $322M | $207M | $115M | $390M | $2026M |
| 2015 | $1691M | $1423M | $268M | $164M | $59M | $105M | $268M | $1258M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $67M | $-525M | $377M | $-16M | $51M | $-2M | |
| 2024 | $59M | $-590M | $575M | $-87M | $-29M | $-3M | |
| 2023 | $60M | $-130M | $-52M | $-44M | $16M | $-82M | |
| 2022 | $81M | $666M | $-722M | $-17M | $64M | $-77M | |
| 2021 | $137M | $78M | $-146M | $-14M | $123M | $-1M | |
| 2020 | $97M | $-775M | $794M | $-18M | $80M | $-36M | |
| 2019 | $72M | $-520M | $411M | $-21M | $51M | $-65M | |
| 2018 | $74M | $-268M | $295M | $-19M | $55M | $-0M | |
| 2017 | $47M | $-380M | $352M | $-8M | $39M | $-0M | |
| 2016 | $31M | $-274M | $252M | $-4M | $27M | $-11M | |
| 2015 | $25M | $-389M | $308M | $-2M | $23M | $-0M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net